(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(0.41%) $79.31
(-0.41%) $2.18
(-0.27%) $2 316.10
(-0.08%) $27.58
(0.34%) $987.90
(0.05%) $0.931
(0.12%) $10.90
(0.03%) $0.800
(0.00%) $91.74
Live Chart Being Loaded With Signals
Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts...
Stats | |
---|---|
Today's Volume | 476.00 |
Average Volume | 0.00 |
Market Cap | 2.30B |
EPS | $-0.170 ( 2023-06-30 ) |
Next earnings date | ( $0 ) 2024-05-15 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 12.30 |
ATR14 | $0 (0.00%) |
Volume Correlation
Dermapharm Holding SE Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Dermapharm Holding SE Correlation - Currency/Commodity
Dermapharm Holding SE Financials
Annual | 2023 |
Revenue: | $1.14B |
Gross Profit: | $342.86M (30.20 %) |
EPS: | $1.160 |
FY | 2023 |
Revenue: | $1.14B |
Gross Profit: | $342.86M (30.20 %) |
EPS: | $1.160 |
FY | 2022 |
Revenue: | $1.02B |
Gross Profit: | $660.83M (64.49 %) |
EPS: | $2.49 |
Financial Reports:
No articles found.
Dermapharm Holding SE
Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, and other healthcare products. It also offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology primarily under the Dekristol, Dekristolvit, Allergovit, and Tromcardin brands. In addition, the company provides medical devices under the bite away and Herpotherm names; Momekort, a nasal spray used to treat allergy symptoms; and Azedil, a nasal spray or eye drop. Further, it imports originator pharmaceuticals under the axicorp brand; and offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. It serves pharmaceutical wholesalers, pharmacies, hospitals, and health food stores. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-Aktiengesellschaft.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators